Simcere Pharmaceutical Group Limited
SMHGF
$0.6697
-$0.0641-8.74%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -133.66% | -107.34% | -16.03% | 91.08% | 187.55% |
| Total Depreciation and Amortization | -1.72% | 0.67% | 3.22% | 6.40% | 12.37% |
| Total Amortization of Deferred Charges | 107.87% | 55.03% | 13.08% | -12.84% | -33.49% |
| Total Other Non-Cash Items | 192.34% | 194.00% | -136.59% | -544.32% | -607.50% |
| Change in Net Operating Assets | -1,246.22% | -1,246.22% | -1,246.22% | -5.04% | 109.16% |
| Cash from Operations | 80.53% | -39.03% | -89.89% | -71.44% | -45.97% |
| Capital Expenditure | -35.90% | -35.90% | -35.90% | -38.74% | -50.94% |
| Sale of Property, Plant, and Equipment | 41,743.48% | 41,743.48% | 41,743.48% | 1,599.21% | -95.74% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -94.93% | 7.67% | -- | 1,728.57% | 797.11% |
| Other Investing Activities | -205.00% | -85.18% | 2.45% | -39.70% | -62.06% |
| Cash from Investing | -169.09% | -57.33% | 937.42% | 144.13% | 26.12% |
| Total Debt Issued | 61.28% | 47.46% | 32.59% | 12.57% | -5.08% |
| Total Debt Repaid | -8.54% | -9.59% | -10.83% | 2.67% | 12.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1,208.93% | -1,798.50% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.30% | -3.30% | -3.30% | 4.59% | 7.76% |
| Other Financing Activities | 2,747.09% | 1,199.44% | 22.90% | 37.22% | 47.16% |
| Cash from Financing | 87.48% | 42.27% | -13.82% | 7.22% | 19.26% |
| Foreign Exchange rate Adjustments | -85.64% | -77.54% | -68.65% | 278.18% | 160.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.99% | -50.12% | -50.79% | -29.81% | -5.87% |